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Infection with cytomegalovirus (CMV), a beta-herpesvirus, is common within the population.  
Although asymptomatic, infection is associated with increased serum concentrations of cytokines 
such as TNFα and IL-6, which are also related to mood and wellbeing.  The present study examined 
whether infection with CMV was associated with mood in a community-based sample of older 
adults.  Blood samples and scores on the General Health Questionnaire were available for 137 
participants.  Serum was analysed for the presence of CMV-specific IgG and the antibody titre was 
used as an indirect measure of viral load. The majority of the participants (66%) were CMV 
seropositive and seropositive status was not associated with psychological morbidity.  However, 
within the CMV positive group, individuals with higher CMV-specific antibody titres were more 
likely to be depressed, anxious, and suffer more overall psychological morbidity.  This association 
could be mediated by the impact of affect-moderating cytokines secreted through the CMV-specific 
immune response. 
 





Cytomegalovirus (CMV) is an ubiquitous β-herpesvirus with prevalence rates of infection as 
high as 90% (Akbar and Fletcher, 2005).  Infection with CMV is usually asymptomatic although it 
may be accompanied by clinical symptoms (Stinski, 1991).  Immunocompromised individuals, such 
as those with HIV infection, often display symptomatic CMV infections such as interstitial retinitis 
or pneumonia (Rasmussen, 1991).  CMV infection may also contribute to immunosenescence 
(Olsson et al., 2000), and thus an increased susceptibility to infectious disease and increased risk of 
mortality in the very old (Almanzar et al., 2005; Pawelec et al., 2005).  CMV is also considered to 
be associated with increased concentrations of pro-inflammatory cytokines, another marker of 
immunosenescence (Forsey et al., 2003; Franceschi et al., 1999; Licastro et al., 2005), including 
TNFά and IL-6 (Trzonkowski et al., 2003), and IFNγ (Almanzar et al., 2005; Khan et al., 2002).  
 
Such cytokines are also related to mood and wellbeing, particularly in the context of infectious or 
inflammatory illness, and are considered to incite sickness behaviours (e.g. fatigue, somnolence) 
(Dantzer, 2006; Kelley et al., 2003), depressed mood (Reichenberg et al., 2001; Wright et al., 2005) 
and anxiety (Maes et al., 1998).  There is also considerable interest in the role of pro-inflammatory 
cytokines in the onset of depression (Anisman and Merali, 2003; Irwin, 2002; Miller and 
O'Callaghan, 2005).  One previous study of individuals with acute Epstein-Barr virus, Ross River 
virus, or Q fever infection (Vollmer-Conna et al., 2004) has documented an association between 
levels of IL-1β and IL-6 and sickness behaviours including anhedonia (inability to enjoy activities), 
impaired concentration, and malaise, which overlap considerably with the symptoms of mild 
depression.  In a recent small scale study, older adults with minor or major depression displayed 
higher CMV antibody titres than matched controls (Trzonkowski et al., 2004).  Similarly, in cardiac 
patients, those reporting greater depressive symptoms were more likely to be seropositive to CMV 
(Miller et al., 2005).  The present study examined whether infection with CMV was associated with 
mood and psychological morbidity in a community-based sample of older adults.  It was 
hypothesised that those with higher CMV antibody titres would report more symptoms of 




Data were available for 137 older adults (62 men and 75 women), recruited from medical 
practices in Birmingham, UK.  All participants were aged 65 years or older (mean = 73.6, SD = 
5.89, range = 65-91 years) and had no history of negative reactions to blood sampling, no acute 
infection, or known current immune disorder.  All but four participants described themselves as 
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“white”; half (51%) of the sample had held non-manual occupations.  The majority (89%) were 
non-smokers and only 24% admitted drinking one unit or more of alcohol per day; 81% indicated 
that they for less than eight hours per night on average.  Sixty-five percent reported some type of 
ongoing chronic medical condition (excluding cancer and diabetes), the most common being and 
hypertension (36%) and rheumatoid arthritis (35%).  Seventy-five percent were taking some type of 
medication (excluding immunosuppressants or enhancers), mainly for high blood pressure (35%), 
and arthritis (8%). The study was approved by the appropriate Research Ethics Committees. 
  
2.2 Study Design 
Elderly patients attending their doctor’s surgery for routine annual influenza vaccination 
were invited to participate.  Those who agreed and met the inclusion criteria provided a single 
venous blood sample before vaccination and took home a questionnaire pack to return by mail.   
 
2.3 Questionnaires 
Standard socio-demographic and clinical information (reported above) was obtained by 
questionnaire.  Participants also completed the General Health Questionnaire (GHQ-28) (Goldberg 
and Williams, 1988) in reference to the past month.  This measure is widely used for detecting 
psychological distress and yields four robust factors with acceptable psychometric 
properties(Goldberg and Williams, 1988): somatic symptoms; anxiety/insomnia; social dysfunction; 
and severe depression.  The simple Likert-type method of scoring (0-1-2-3) was used.  Participants’ 
health behaviours were assessed with reference to the previous year by questionnaire, for full details 
see (Phillips et al., 2006).   
 
2.4 Blood samples, and virological assays 
Venous blood was collected from an ante-cubital vein into a plain 7ml tube (BD Vacutainer, 
Meylan Cedex).  The samples were allowed to clot for at least one hour, were centrifuged at 3500 
rpm for 5 min, and the separated serum was frozen at −20 °C until assayed.  Serum was analysed 
for the presence of CMV infection by quantitative determination of CMV-specific IgG antibody 
titre in duplicate using a standard enzyme immunoassay kit (BioCheck Inc, California) with a 
sensitivity of 100%, specificity of 97.6%, and accuracy of 99%.  The coefficients of inter-assay 
variation were all <10%.  In this test, individuals with a serum IgG titre of >1.2 IU/ml are 
considered to be seropositive, indicating prior exposure to the virus.   
 
2.5 Data Reduction and Analysis 
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As scores on the GHQ-28 and its sub-scales were highly skewed, binary variables (high and 
low) were created using median splits.  Chi-square and logistic regression were used to determine 
whether CMV status and titres (as separate independent variables) predicted mood and well-being.  
Where demographic and health behaviour variables were found to be associated with either CMV 
status/titre or GHQ-28 subscale scores, these variables were entered into the logistic regressions at 
step one, with the relevant independent variable (CMV serostatus or titre) entered at step two. 
 
3. Results 
3.1 CMV and Questionnaire Data 
The majority of the participants (66%) were CMV seropositive.  Amongst those, the mean 
CMV-specific antibody titre was 16.4 (4.86) mIU.  Participants’ mean GHQ-28 score was 15.5 (SD 
= 7.46), and their mean (SD) scores on each of the subscales were: 3.7 (2.88) for somatic 
symptoms; 3.8 (3.18) for anxiety; 7.3 (1.92) for social dysfunction; and 0.8 (1.68) for depression.   
 
3.2 Associations between CMV and Mood 
CMV seropositive status was not associated with high or low levels of psychological 
morbidity on the GHQ.  However, of those who were CMV seropositive, individuals with higher 
CMV-specific antibody titres were more likely to report higher depressive symptoms, OR = 1.18 
95% CI 1.04 – 1.33, p = .01, anxiety, OR = 1.17 95% CI 1.05 – 1.31, p = .005, and suffer more 
overall psychological morbidity, OR = 1.16 95% CI 1.04 – 1.29, p = .008.  The associations with 
depression and anxiety are presented in Figure 1. 
 
3.3 Demographic, Clinical, and Health Behaviour Variables 
CMV serostatus was not associated with any of the demographic, clinical, or health 
behaviour variables, although there was a tendency for more participants from manual occupational 
groups to be CMV seropositive, χ2(1) = 3.23, p = .07.  Among the CMV seropositive cohort, none 
of the demographic, clinical, or health behaviour variables were associated with CMV antibody 
titre.  GHQ scores were not related to any of the demographic, clinical, or health behaviour 
variables, although there was a tendency for women, t(135) = 1.83, p = .07, and those taking 
medication, t(128) = 1.73, p =  .09, to register higher anxiety scores.  Entering sex and medication 
status at step 1 in the logistic regression model failed to attenuate the association between CMV 
titre and anxiety, OR = 1.21, 95% CI 1.07 – 1.37, p = .002, or with depression, OR = 1.18, 95% CI 
1.04 – 1.33, p = .01.  Although there were no significant associations between CMV or GHQ scores 
and chronic illness status or medication usage, the numbers of participants with inflammatory 
disorders and taking medication for these illnesses was relatively high.  Consequently we created 
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binary variables for the most common diseases and medications: hypertension, arthritis, anti-
hypertensive medication, and arthritis medication.  Several logistic regressions were then 
undertaken, entering these variables at step 1 either separately or together.  Neither type of disease 
or medication attenuated the significant associations observed between CMV-specific antibody titre 




In this study we observed that the titre of CMV-specific IgG antibody was positively 
associated with reports of depression and anxiety; individuals exhibiting higher antibody titres 
against CMV reported more symptoms of depression and anxiety.  CMV seropositive individuals as 
a group were not at an increased risk of negative mood suggesting that infection alone is not the 
primary risk factor. Higher CMV-specific antibody titres reflect recent or reactivated CMV 
infection (Musiani et al., 1988) and there is evidence that they are correlated with the CMV 
antigenemia test which is a quantitative marker for CMV load (van Zanten et al., 1995).  In addition 
the increase in the titre of CMV-specific IgG that is observed in association with ageing is believed 
the reflect the increased frequency of viral reactivation within this cohort (Stowe et al., 2007; 
Torfason et al., 1981).  The implication of our findings is that it is the magnitude of the CMV-
specific immune response, rather than CMV infection itself, that is associated with symptoms of 
depression and anxiety. The present findings resonate with those of a recent small-scale study of 
older adults with clinical depression who displayed higher CMV antibody titres, higher levels of 
serum and in vitro stimulated IL-6, and higher stimulated concentrations of TNFά, compared to 
non-depressed controls (Trzonkowski et al., 2004).  Our results appear to contrast somewhat with 
those of Miller et al. (2005) who reported that seropositivity to CMV in cardiac patients was 
correlated with level of depressive symptoms irrespective of antibody titre.  However, the 
association between CMV infection and mood may be differently manifest in cardiac patients who 
have recently experienced an acute coronary syndrome compared to a broader population sample.  
Further, differences between studies in the criterion for determining the cut-off for seropositivity 
make direct comparison difficult.  
 
A limitation of the present analysis is the cross-sectional design which limits the ability to assign 
causality.  As higher antibody titres against CMV have been associated with increased 
concentrations of pro-inflammatory cytokines in clinically depressed older adults (Trzonkowski et 
al., 2004), it is probable that CMV titre contributes to feelings of anxiety and depression.  However, 
it also remains possible that the relationship between these variables is in the opposite direction.  
Symptoms of depression and anxiety could induce CMV reactivation, resulting in greater antibody 
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titres against the virus, given that such effects have been previously attributed to psychological 
stress (Glaser et al., 1985; Mehta et al., 2000).  A prospective longitudinal design would be 
necessary to discount this possibility.  Of course it could also be the case that some third 
unmeasured factor, such as underlying vascular disease which is related to CMV status (Nieto et al., 
1996) and symptoms of depression (Tiemeier et al., 2004), could mediate the association observed 
here.  However, statistical adjustment for hypertension and arthritis failed to attenuate the 
significant associations observed.  Future studies might include multiple assessments of mood and 
CMV titre in order to better establish the most likely direction of effect and might also examine 
underlying mechanisms by measuring concentrations of pro-inflammatory cytokines, including 
TNFά, IL-6, IL-1β, and IFNγ.  It would also be interesting to examine the association between 
CMV and psychological status in older adults already displaying concomitant immunosenescence. 
 
In summary, the present study provides preliminary evidence that the magnitude of the CMV-
specific immune response is associated with psychological morbidity in a community sample of 
older adults. This underscores the powerful link between immunological and psychological 
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Figure 1: CMV titres for those with low and high depression and anxiety scores 
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